SciTech Fund

SciTech Fund focuses on early-stage and seed investments, typically providing initial institutional capital to ventures still proving their technology. The firm's mandate centers on supporting companies through the transition from lab-scale innovation to first commercial traction, a stage where Central European startups historically face acute funding gaps.

Lublin is home to several major research universities, including the Medical University of Lublin and Lublin University of Technology, producing a steady stream of scientific research with commercial potential. By operating outside Poland's primary venture hubs, SciTech Fund positions itself to capture deal flow that originates in the local academic ecosystem before it reaches better-funded competitors in Warsaw or Kraków.

The firm's capital structure is not publicly disclosed. Its '.vc' domain and asset-manager designation suggest it may raise capital from external limited partners, but no fund closes, LP names, or regulatory filings are publicly available to confirm the source of its investment capital.

SciTech Fund targets science and technology ventures broadly, with an emphasis on companies commercializing university research. Based on the profile of Lublin's research output, likely areas of interest include life sciences, medical devices, biotech, advanced materials, and engineering technologies, though the firm has not published a formal sector-exclusion policy.

The firm's Lublin location suggests a sourcing model built on close relationships with local universities, research institutes, and technology transfer offices. This campus-adjacent posture is consistent with deep-tech funds globally that prioritize proprietary access to academic spinouts before they enter broader syndication.